An open-label randomized clinical trial to evaluate the efficacy of everolimus versus tacrolimus in triple maintenance immunosuppressive therapy for kidney transplant patients

Tacrolimus (TAC), a calcineurin inhibitor, and everolimus (EVL), an mTOR inhibitor, have been used as immunosuppressive (ISS) drugs in post-kidney transplantation therapy. The objective of this study was to compare the efficacy of EVL vs TAC in the ISS maintenance triple therapy. Ninety-seven kidney...

Full description

Bibliographic Details
Main Authors: B.P.S. Assis, M.F. Lasmar, R.A. Fabreti-Oliveira, S.A. Araujo, J. Oliveira, D.C. Wanderley, E. Nascimento
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/pdf/bjmbr/v54n4/1414-431X-bjmbr-54-4-e9369.pdf

Similar Items